| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.83▲ | 1.85▲ | 1.85▲ | 1.78▲ | 1.79▲ |
| MA10 | 1.81▲ | 1.81▲ | 1.78▲ | 1.79▲ | 1.87▲ |
| MA20 | 1.79▲ | 1.79▲ | 1.81▲ | 1.75▲ | 1.98▼ |
| MA50 | 1.77▲ | 1.77▲ | 1.79▲ | 1.87▲ | 2.06▼ |
| MA100 | 1.77▲ | 1.73▲ | 1.83▲ | 2.00▼ | 2.02▼ |
| MA200 | 1.85▲ | 1.87▲ | 1.84▲ | 2.08▼ | 12.65▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.015▲ | 0.015▲ | 0.012▲ | 0.022▲ | -0.003▼ |
| RSI | 60.736▲ | 59.640▲ | 58.989▲ | 55.337▲ | 48.378▼ |
| STOCH | 76.957 | 93.478▲ | 75.000 | 63.376 | 31.933 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -10.256▲ | -50.000 |
| CCI | 152.450▲ | 143.385▲ | 134.238▲ | 121.103▲ | -3.153 |
|
Thursday, July 03, 2025 05:20 AM
A 1‑for‑10 reverse stock split consolidates shares but not value. Learn how it works, why it's done, and see other recent examples ...
|
|
Thursday, July 03, 2025 05:20 AM
Similarly, China Pharma Holdings, Inc. (NYSE:CPHI) carried out its 1‑for‑10 reverse split effective April 15, 2025, citing ongoing efforts to meet continued listing standards. As with the ...
|
|
Thursday, April 10, 2025 05:00 PM
Shares of China Pharma Holdings, Inc. (NYSE:CPHI – Free Report) are scheduled to reverse split on the morning of Tuesday, April 15th. The 1-10 reverse split was announced on Friday, April 4th.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/07/25 | 1.78 | 1.94 | 1.72 | 1.90 | 28,400 |
| 10/07/25 | 1.70 | 1.86 | 1.68 | 1.84 | 267,700 |
| 09/07/25 | 1.69 | 1.77 | 1.62 | 1.70 | 231,200 |
| 08/07/25 | 1.69 | 1.84 | 1.69 | 1.76 | 12,500 |
| 07/07/25 | 1.88 | 1.88 | 1.65 | 1.70 | 44,600 |
| 03/07/25 | 1.74 | 1.85 | 1.74 | 1.84 | 21,000 |
| 02/07/25 | 1.80 | 1.88 | 1.70 | 1.75 | 322,000 |
| 01/07/25 | 1.77 | 1.88 | 1.76 | 1.81 | 9,400 |
| 30/06/25 | 1.85 | 1.86 | 1.78 | 1.79 | 34,300 |
| 27/06/25 | 1.73 | 1.87 | 1.70 | 1.83 | 36,500 |
|
|
||||
|
|
||||
|
|